GGrantIndex
← Leaderboards

Joseph A Lorenzo

University Of Connecticut Sch Of Med/Dnt

$6,213,979
Attributed
$7,110,261
Total exposure
11
Grants
10
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $813.7K · FY200525
$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$9,401,951 · 12

By mechanism

R01$6,065,554 · 3
P30$2,291,690 · 1
R56$411,729 · 1
R21$391,468 · 1
P01$156,510 · 1
R13$85,000 · 5

Top collaborators

Most similar at University Of Connecticut Sch Of Med/Dnt

Same institution · by research overlap

Others in their field

Top investigators on “Osteoclasts

Research focus

OsteoclastsBone MarrowCellsHomeostasisIn VivoSitePhenotypeOsteoporosisSignal TransductionBoneApoptosisPrecursor CellBone CallusMolecularFractureOsteolysisProgenitorRepairedBone ResorptionMyelogenousBone RemodelingHomingBloodBone Turnover

Grant awards (34)

Studies of Osteoclast Lineage in Health and Diseases$429,260
R01 · FY2025 · AR · contact PI
Studies of Osteoclast Lineage in Health and Diseases$425,998
R01 · FY2024 · AR · contact PI
Studies of Osteoclast Lineage in Health and Diseases$435,905
R01 · FY2023 · AR · contact PI
Studies of Osteoclast Lineage in Health and Diseases$428,406
R01 · FY2022 · AR · contact PI
Studies of Osteoclast Lineage in Health and Diseases$214,827
R01 · FY2021 · AR · contact PI
Parmodulins as an Anti-Resorptive and Anti-Inflammatory Therapy for Metabolic Bone Disease$174,988
R21 · FY2021 · AR · contact PI
Parmodulins as an Anti-Resorptive and Anti-Inflammatory Therapy for Metabolic Bone Disease$216,480
R21 · FY2020 · AR · contact PI
Eighth International Conference on Osteoimmunology$23,000
R13 · FY2020 · AR · contact PI
Studies of Osteoclast Lineage in Health and Disease$411,729
R56 · FY2019 · AR · contact PI
Runx1 Control of Bone Resorption during Fracture Repair$338,938
R01 · FY2017 · AR · contact PI
Runx1 Control of Bone Resorption during Fracture Repair$338,938
R01 · FY2016 · AR · contact PI
Runx1 Control of Bone Resorption during Fracture Repair Supplement$100,000
R01 · FY2016 · AR
Runx1 Control of Bone Resorption during Fracture Repair$338,938
R01 · FY2015 · AR
Runx1 Control of Bone Resorption during Fracture Repair$337,875
R01 · FY2014 · AR
Runx1 Control of Bone Resorption during Fracture Repair$337,875
R01 · FY2013 · AR
4th Int'l Conference on Osteoimmunology: Interactions of the Immune & Skeletal Sy$15,000
R13 · FY2012 · AR · contact PI
STUDIES ON THE REGULATION OF OSTEOCLAST PRECURSOR CELLS$309,450
R01 · FY2011 · AR · contact PI
STUDIES ON THE REGULATION OF OSTEOCLAST PRECURSOR CELLS$322,344
R01 · FY2010 · AR · contact PI
The Third International Conference on Osteoimmunology: Interactions of the Immune$15,000
R13 · FY2010 · AR · contact PI
STUDIES ON THE REGULATION OF OSTEOCLAST PRECURSOR CELLS$325,600
R01 · FY2009 · AR · contact PI
STUDIES ON THE REGULATION OF OSTEOCLAST PRECURSOR CELLS$325,600
R01 · FY2008 · AR · contact PI
The 2nd International Conference on Osteoimmunology$15,000
R13 · FY2008 · AR · contact PI
"The 1st International Conference on Osteoimmunology: Interactions of the Immune$17,000
R13 · FY2006 · AR · contact PI
Core Center for Musculoskeletal Research$575,899
P30 · FY2005 · AR
Studies of CD45R/B220+ osteoclast precursor$237,800
R01 · FY2005 · AR
Core Center for Musculoskeletal Research$569,316
P30 · FY2004 · AR
Studies of CD45R/B220+ osteoclast precursor$272,600
R01 · FY2004 · AR
Core Center for Musculoskeletal Research$573,345
P30 · FY2003 · AR
Studies of CD45R/B220+ osteoclast precursor$272,600
R01 · FY2003 · AR
Core Center for Musculoskeletal Research$573,130
P30 · FY2002 · AR
Studies of CD45R/B220+ osteoclast precursor$272,600
R01 · FY2002 · AR
ESTROGEN REGULATION OF CYTOKINE RESPONSIVENESS IN BONE--OSTEOCLASTOGENESIS$0
P01 · FY2002 · AR
ESTROGEN REGULATION OF CYTOKINE RESPONSIVENESS IN BONE--OSTEOCLASTOGENESIS$0
P01 · FY2001 · AR
ESTROGEN REGULATION OF CYTOKINE RESPONSIVENESS IN BONE--OSTEOCLASTOGENESIS$156,510
P01 · FY2000 · AR